Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.

BMC public health - 2 May 2015

Riethmuller Didier, Jacquard Anne-Carole, Lacau St Guily Jean, Aubin François, Carcopino Xavier, Pradat Pierre, Dahlab André, Prétet Jean-Luc

Abstract excerpt

BACKGROUND: Human Papillomavirus (HPV) infection is known to be associated with a number of conditions including cervical, vaginal, vulvar, penile, anal neoplasias and cancers, oropharynx cancers and genitals warts (GW). Two prophylactic vaccines are currently available: a bivalent vaccine designed to prevent HPV type 16 and 18 infection and a quadrivalent vaccine targeting HPV 6, 11, 16, and 18. In France, HPV...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alphapapillomavirus
Share to Anus Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to France

Share to Oropharyngeal Neoplasms

Share to Papillomavirus Infections

Share to Papillomavirus Vaccines

Share to Prevalence

Share to Uterine Cervical Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 25934423
DOI: 10.1186/s12889-015-1779-1
PMCID: PMC4433025

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.PMID 25934423Read ↗

Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: A referral hospital-based study in Sicily.Semantic proximity Read ↗

Potential impact of introducing a nonavalent HPV vaccination.Semantic proximity Read ↗

Potential impact of a 9-valent HPV vaccine in HPV-related cervical disease in 4 emerging countries (Brazil, Mexico, India and China).Semantic proximity Read ↗

Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions.Semantic proximity Read ↗

HPV genotype prevalence in Indian women with cervical disease and estimation of the potential impact of HPV vaccines on prevention of cervical cancer.Semantic proximity Read ↗

Projected health and economic effects of nonavalent versus bivalent human papillomavirus vaccination in preadolescence in the NetherlandsSemantic proximity Read ↗

Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain.Semantic proximity Read ↗

Cervical intraepithelial neoplasia grade 2 or worse in Galicia, Spain: HPV 16 prevalence and vaccination impact.Semantic proximity Read ↗

Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review.Semantic proximity Read ↗

[Preventing cancer: The role of Papillomavirus vaccination in the general population].Semantic proximity Read ↗

Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types.Semantic proximity Read ↗

Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young WomenSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.